Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1

Matthew G. Mutch, Margaret M. Frisella, Mary K. DeBenedetti, Gerard M. Doherry, Jeffrey A. Norton, Samuel A. Wells, Terry C. Lairmore

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Background. The usefulness of human pancreatic polypeptide (hPP) as a plasma marker for islet cell neoplasms is controversial. We sought to determine the relation between fasting plasma hPP levels and radiographically detectable pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1 (MEN 1). Methods. Fasting plasma hPP levels were measured prospectively in 202 individuals from 31 independent kindreds with MEN 1. Plasma levels greater than 3.0 times the normal age-specific values were defined as elevated. Patients with elevated plasma hPP levels were evaluated with computed tomographic scanning and magnetic resonance imaging, octreotide scanning or selective angiography. Results. Twenty-two patients had elevated fasting plasma hPP levels, and 20 of these patients were evaluated radiographically. Pancreatic lesions were detected in 19 patients. A group of eight patients with normal basal fasting plasma hPP levels were evaluated with computed tomography, magnetic resonance imaging, octreotide scanning, or selective angiography based on clinical presentation. One patient in this group had an imaging study that was positive for a pancreatic lesion. Conclusions. The presence of a markedly elevated fasting plasma hPP level in patients with MEN 1 is 95 % sensitive and 88 % specific for the presence of radiographically detectable pancreatic islet cell tumors.

Original languageEnglish
Pages (from-to)1012-1020
Number of pages9
JournalSurgery
Volume122
Issue number6
DOIs
StatePublished - Dec 1997

Fingerprint Dive into the research topics of 'Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1'. Together they form a unique fingerprint.

  • Cite this